Icon

VYALEV - (120MG/10ML;2400MG/10ML)

FOSCARBIDOPA; FOSLEVODOPA None
120MG/10ML;2400MG/10ML
Less Than $1000 mn
None None
None None
None None
VYALEV is a combination of foscarbidopa (an aromatic amino acid decarboxylation inhibitor) and foslevodopa (an aromatic amino acid) indicated for the treatment of motor fluctuations in adults with advanced Parkinson’s disease.
Yes
VYALEV Patent 1 Patent 2 Patent 3 Patent 4
*** *********

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.